Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance. (2014)

First Author: Chatzigeorgiou A
Attributed to:  MRC Centre for Transplantation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1400419111

PubMed Identifier: 24492375

Publication URI: http://europepmc.org/abstract/MED/24492375

Type: Journal Article/Review

Volume: 111

Parent Publication: Proceedings of the National Academy of Sciences of the United States of America

Issue: 7

ISSN: 0027-8424